JP2015535240A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015535240A5 JP2015535240A5 JP2015538828A JP2015538828A JP2015535240A5 JP 2015535240 A5 JP2015535240 A5 JP 2015535240A5 JP 2015538828 A JP2015538828 A JP 2015538828A JP 2015538828 A JP2015538828 A JP 2015538828A JP 2015535240 A5 JP2015535240 A5 JP 2015535240A5
- Authority
- JP
- Japan
- Prior art keywords
- decline
- salt
- brain function
- agent
- ability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015538828A JP6170166B2 (ja) | 2012-10-30 | 2013-10-30 | 脳機能低下の予防または改善剤 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012238541 | 2012-10-30 | ||
| JP2012238541 | 2012-10-30 | ||
| JP2015538828A JP6170166B2 (ja) | 2012-10-30 | 2013-10-30 | 脳機能低下の予防または改善剤 |
| PCT/JP2013/080052 WO2014069666A1 (en) | 2012-10-30 | 2013-10-30 | Agent for preventing or improving decline in brain function |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015535240A JP2015535240A (ja) | 2015-12-10 |
| JP2015535240A5 true JP2015535240A5 (enExample) | 2016-12-15 |
| JP6170166B2 JP6170166B2 (ja) | 2017-07-26 |
Family
ID=50627558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015538828A Active JP6170166B2 (ja) | 2012-10-30 | 2013-10-30 | 脳機能低下の予防または改善剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10369186B2 (enExample) |
| EP (1) | EP2914257B1 (enExample) |
| JP (1) | JP6170166B2 (enExample) |
| AU (1) | AU2013339057B2 (enExample) |
| CA (1) | CA2888791C (enExample) |
| ES (1) | ES2728471T3 (enExample) |
| NZ (1) | NZ706862A (enExample) |
| WO (1) | WO2014069666A1 (enExample) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1110392A (en) * | 1964-09-28 | 1968-04-18 | Yamanouchi Pharma Co Ltd | Composition containing glutathione and an amino acid or amino acids, and salts thereof |
| US20010056068A1 (en) | 1998-03-04 | 2001-12-27 | Kristof Chwalisz | Method of treatment and prevention of nitric oxide deficiency-related disorders with citrulline and citrulline derivatives |
| AU5939901A (en) * | 2000-10-27 | 2002-05-06 | Nitromed Inc | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| AU2002333018B2 (en) * | 2001-09-27 | 2006-08-31 | The Mental Health Research Institute Of Victoria | Modulation of physiological processes and agents useful for same |
| US20060046982A1 (en) * | 2004-08-26 | 2006-03-02 | Waugh William H | Orthomolecular medical use of L-citrulline for capillary endothelial protection and adjacent cell protection in neurodegenerative disease |
| JP4137906B2 (ja) * | 2005-03-30 | 2008-08-20 | ピアス株式会社 | セラミダーゼ阻害剤 |
| US20090047340A1 (en) * | 2006-03-29 | 2009-02-19 | Guilford F Timothy | Liposomal reduced glutathione and 1-arginine, including with other ingredient(s), capable of multipath administration for reversal and prevention of obesity and for mitochondrial biogenesis |
| US8597640B2 (en) | 2007-10-31 | 2013-12-03 | University Of Massachusetts Lowell | Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging |
| AU2008347177B2 (en) * | 2008-01-04 | 2014-04-17 | Société des Produits Nestlé S.A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions |
| WO2009096505A1 (ja) * | 2008-01-30 | 2009-08-06 | Kyowa Hakko Bio Co., Ltd. | 注意集中力向上剤 |
| US9918951B2 (en) | 2008-02-05 | 2018-03-20 | Kyowa Hakko Bio Co., Ltd. | Method for improving storage stability of glutathione |
| JP2010126462A (ja) * | 2008-11-26 | 2010-06-10 | Mitsubishi Gas Chemical Co Inc | 脳機能改善用組成物および該組成物を含有する機能性食品 |
-
2013
- 2013-10-30 JP JP2015538828A patent/JP6170166B2/ja active Active
- 2013-10-30 CA CA2888791A patent/CA2888791C/en active Active
- 2013-10-30 EP EP13851411.2A patent/EP2914257B1/en active Active
- 2013-10-30 WO PCT/JP2013/080052 patent/WO2014069666A1/en not_active Ceased
- 2013-10-30 ES ES13851411T patent/ES2728471T3/es active Active
- 2013-10-30 NZ NZ706862A patent/NZ706862A/en unknown
- 2013-10-30 AU AU2013339057A patent/AU2013339057B2/en active Active
- 2013-10-30 US US14/435,679 patent/US10369186B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015535241A5 (enExample) | ||
| WO2015067715A3 (en) | Gip-glp-1 dual agonist compounds and methods | |
| WO2016066744A3 (en) | Gip agonist compounds and methods | |
| DK3313991T3 (da) | Modificeret faktor ix og sammensætninger, fremgangsmåder og anvendelser til genoverførsel til celler, organer og væv | |
| WO2015019348A3 (en) | Photocatalysts based on bismuth oxyhalide, process for their preparation and uses thereof | |
| JP2014530840A5 (enExample) | ||
| WO2014133855A8 (en) | Tuberculosis biomarkers and uses thereof | |
| WO2012100097A3 (en) | Topical minocycline compositions and methods of using the same | |
| WO2015023681A3 (en) | Swallowing assessment and improvement systems and methods | |
| WO2015077503A8 (en) | Autotaxin inhibitor compounds | |
| JP2012531301A5 (enExample) | ||
| WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
| EP2683373C0 (de) | Orthomolekulares mittel gegen die folgen von alkoholkonsum | |
| EP2920332A4 (en) | SELF-ADJUSTING FORM MEMORY ALLOYS WITH EXTREMELY LOW ELASTICITY MODULE | |
| JP2014022036A5 (enExample) | ||
| JP2015096476A5 (enExample) | ||
| NZ707081A (en) | Agent for preventing or improving decline in brain function | |
| WO2015026494A3 (en) | Methods for treating tissue fibrosis | |
| JP2013533867A5 (enExample) | ||
| AT12000U3 (de) | Maske und lagerungsvorrichtung für die radiologische diagnostik und/oder radioonkologische behandlung | |
| WO2014130313A3 (en) | Methods and compositions relating to the treatment of cancer | |
| WO2014031982A3 (en) | Methods and compositions for treating pain | |
| HK1203379A1 (en) | β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF | |
| BR112016028662B8 (pt) | Composições herbicidas sólidas na forma de grânulos contendo um agente de proteção, e seu método de preparação | |
| JP2013100268A5 (enExample) |